Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.
Abbott Laboratories (NYSE: ABT) shares declined 0.49 percent to close at $34.86 a share Tuesday. The stock traded between $34.65 and $35.31 on volume of 5.31 million shares traded. According to various reports, China’s National Development and Reform Commission are investigating foreign infant formula makers for violating anti-monopoly laws.
Get more information on Abbott Laboratories and free access to the in-depth equity report at:
www.FiveStarEquities.com/ABT
CACI International Inc. (NYSE: CACI) shares declined 4.58 percent to close at $61.30 a share Tuesday. The stock traded between $60.68 and $63.60 on volume of 774,530 shares traded. Analysts at RBC Capital Markets have recently downgraded the company’s rating to “underperform” from “sector perform”. Shares of CACI International have gained approximately 11.4 percent year-to-date.
Get more information on CACI International and free access to the in-depth equity report at:
www.FiveStarEquities.com/CACI
LinnCo LLC (NASDAQ: LNCO) shares plunged 16.64 percent to close at $30.90 a share Tuesday. The stock traded between $30.25 and $33.43 on volume of 4.97 million shares traded. The company announced it is being investigated by the Securities and Exchange Commission. Shares of LinnCo have fallen approximately 14.5 percent year-to-date.
Get more information on LinnCo and free access to the in-depth equity report at:
www.FiveStarEquities.com/LNCO
MAXIMUS, Inc. (NYSE: MMS) shares declined 4.36 percent to close at $36.00 a share Tuesday. The stock traded between $34.65 and $37.38 on volume of 3.71 million shares traded. The company expects revenues for fiscal 2014 to be in the range of $1.555 billion and $1.650 billion. Shares of MAXIMUS have gained approximately 14.0 percent year-to-date.
Get more information on MAXIMUS and free access to the in-depth equity report at:
www.FiveStarEquities.com/MMS
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.
Contact:
Five Star Equities
info@fivestarequities.com